Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
266 hedge funds and large institutions have $3.65B invested in Exact Sciences in 2017 Q2 according to their latest regulatory filings, with 66 funds opening new positions, 84 increasing their positions, 87 reducing their positions, and 24 closing their positions.
175% more first-time investments, than exits
New positions opened: 66 | Existing positions closed: 24
52% more capital invested
Capital invested by funds: $2.41B → $3.65B (+$1.24B)
18% more funds holding
Funds holding: 225 → 266 (+41)
3% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 87
4.91% less ownership
Funds ownership: 92.14% → 87.23% (-4.9%)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
60% less call options, than puts
Call options by funds: $65.9M | Put options by funds: $165M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$73.5M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$67.3M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$41.8M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$27M |
| 5 |
Morgan Stanley
New York
|
+$26.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$96.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$63.1M |
| 3 |
JP Morgan Chase
New York
|
-$38.5M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$31.1M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
-$29.9M |
EXAS Hedge Fund Activity: Q2 2017 in Review
266 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q2 2017, worth a combined $3.65B — up 52% from $2.41B a quarter earlier.
Buyers outnumbered sellers: 66 funds opened new EXAS positions and 24 closed out — a net gain of 42 holders — while 84 added to existing stakes and 87 trimmed.
The largest buyer was Fred Alger Management, opening a new position worth an estimated $73.5M. The largest seller was Millennium Management, cutting an estimated $96.2M.
- 266 institutional investors held Exact Sciences (EXAS) as of Q2 2017, up from 225 in Q1 2017.
- Funds reported $3.65B of Exact Sciences stock for Q2 2017, up 52% quarter-over-quarter.
- 66 funds opened new Exact Sciences positions in Q2 2017 and 24 closed out, a net change of +42 holders.
- The largest Exact Sciences buyer in Q2 2017 was Fred Alger Management, an estimated $73.5M added.
- The largest Exact Sciences seller in Q2 2017 was Millennium Management, an estimated $96.2M sold.
Based on aggregated 13F filings for Q2 2017.